United States: Inching Toward Harmonization: FDA Finalizes Rule On IRB Waiver Of Informed Consent For Minimal Risk Studies - Ropes & Gray LLP
Friday, 23 February 2024 On December 21, 2023, the U.S. Food and Drug Administration ("FDA") published a final rule to allow institutional review boards ("IRBs") to waive or alter informed consent for certain clinical...
FDA approves clinical research without informed consent in situations of ‘minimal risk.’ Fluoride trials continue in the courts. Biotechnology innovations for warfare in the works. And that’s not..